Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Advanced Electronic Vaporizer Delivers Desflurane Better

By HospiMedica International staff writers
Posted on 07 Oct 2019
A new vaporizer uses a combination of innovative technologies and a patented design to assure accurate Desflurane delivery, even at low flow rates.

The Penlon (Abingdon, United Kingdom) Sigma EVA is specifically intended to provide a better way to deliver of Desflurane, an ether inhalational general anesthetic agent that it is gradually replacing isoflurane for human use, due to its low solubility in blood. More...
Feature of the Sigma EVA include easy installation and use, a fast warm-up time, an improved filling system, and a 30-minute battery backup. It is compatible with Selectatec and Dräger Auto-Exclusion mounting systems, which allows it be fitted to the vast majority of anaesthesia systems.

Desflurane is structurally identical to isoflurane, except for the substitution of a fluorine atom for the chlorine atom on the α-ethyl carbon. It’s relatively low boiling point (23.5°C) makes it extremely volatile; but as this temperature is close to ambient operating theater temperature, full vapor saturation cannot be guaranteed if a conventional vaporizer is employed. A vaporizer which heats the agent to 39°C at a pressure of two atmospheres is thus needed to ensure full vapor saturation, together with the addition of a carefully regulated amount of vapor to the fresh gas flow (FGF).

“The Sigma EVA is a real achievement, using a combination of innovative technologies and a patented design that results in a product that delivers accurate agent delivery,” said Cliff Kersey, head of new product development at Penlon. “The newest addition to our vaporizer range, the Penlon Sigma EVA is an innovative electronic vaporizer that heats and maintains Desflurane to a constant temperature and pressure, delivering highly accurate output.”

Desflurane has the lowest blood/gas solubility (0.42) of all common anesthetic agents, as compared to diethyl-ether (12); halothane (2.3); enflurane (1.9); isoflurane (1.3); sevoflurane (0.67); and nitrous oxide (0.47). The lower blood/gas solubility allows anesthetic alveolar concentration to remain near inspired concentration, permitting a rapid and large change, with precise control, in the anesthetic depth, and early awakening.

Related Links:
Penlon


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.